Harnessing the power of Vδ2 cells in cancer immunotherapy
about
Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment.Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?
P2860
Q38728528-C0771934-37CF-4A66-9D0B-23ECA20AA481Q40213985-13CDBEEC-66A7-49D2-995E-B6E8BA5D3F11Q50144881-0C113457-CD59-4835-A54C-F1E4510049D3Q52597632-0A7B31B2-D4DE-4260-891A-AAD9DD077DD1Q52731753-A49FD282-9991-4D30-B657-8F037039E893Q52780147-E711D882-F933-46B1-BC4D-E09C09D858C6Q55030400-757AC497-56F8-45B5-9E68-E385DA685482
P2860
Harnessing the power of Vδ2 cells in cancer immunotherapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Harnessing the power of Vδ2 cells in cancer immunotherapy
@ast
Harnessing the power of Vδ2 cells in cancer immunotherapy
@en
Harnessing the power of Vδ2 cells in cancer immunotherapy
@nl
type
label
Harnessing the power of Vδ2 cells in cancer immunotherapy
@ast
Harnessing the power of Vδ2 cells in cancer immunotherapy
@en
Harnessing the power of Vδ2 cells in cancer immunotherapy
@nl
prefLabel
Harnessing the power of Vδ2 cells in cancer immunotherapy
@ast
Harnessing the power of Vδ2 cells in cancer immunotherapy
@en
Harnessing the power of Vδ2 cells in cancer immunotherapy
@nl
P2860
P356
P1476
Harnessing the power of Vδ2 cells in cancer immunotherapy
@en
P2093
D. W. Fowler
M. D. Bodman-Smith
P2860
P356
10.1111/CEI.12564
P407
P577
2015-04-01T00:00:00Z